PYC pyc therapeutics limited

Ann: Fourfold Delivery Improvement in a New Lead Candidate, page-36

  1. 35,790 Posts.
    lightbulb Created with Sketch. 555
    I’m guessing through the quarterly and decision to move lead focus to antisense they will be trying to deliver those compounds to other areas outside of liver tissue ?

    Still a long road though when they talk about trying to put anything in humans - i’d be guessing 2020/21 at earliest ?

    They really need a deal and somebody that wants to pay them something more than the 5 before it ?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.28
Change
-0.005(0.39%)
Mkt cap ! $746.5M
Open High Low Value Volume
$1.29 $1.29 $1.28 $4.538M 3.587M

Buyers (Bids)

No. Vol. Price($)
2 25835 $1.26
 

Sellers (Offers)

Price($) Vol. No.
$1.29 67637 4
View Market Depth
Last trade - 11.26am 26/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.